Sana Biotechnology, Inc. financial data

Symbol
SANA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
188 East Blaine Street, Suite 400, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 459 % +22.5%
Debt-to-equity 82.5 % +15%
Return On Equity -71.6 % +8.51%
Return On Assets -39.2 % +13.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 222M shares +13%
Common Stock, Shares, Outstanding 222M shares +12.9%
Entity Public Float 600M USD -50%
Common Stock, Value, Issued 22K USD +10%
Weighted Average Number of Shares Outstanding, Basic 234M shares +21.8%
Weighted Average Number of Shares Outstanding, Diluted 234M shares +21.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 246M USD -12.4%
General and Administrative Expense 72.7M USD +0.71%
Operating Income (Loss) -253M USD +31.3%
Net Income (Loss) Attributable to Parent -245M USD +32.3%
Earnings Per Share, Basic -1.14 USD/shares +39.7%
Earnings Per Share, Diluted -1.14 USD/shares +39.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 135M USD -22.3%
Marketable Securities, Current 117M USD -23.3%
Assets, Current 263M USD -22.2%
Property, Plant and Equipment, Net 85.9M USD +37.1%
Operating Lease, Right-of-Use Asset 63.2M USD -33.3%
Intangible Assets, Net (Excluding Goodwill) 59.2M USD 0%
Goodwill 141M USD 0%
Other Assets, Noncurrent 6.33M USD -8.63%
Assets 619M USD -12.5%
Accounts Payable, Current 3.82M USD +23.6%
Employee-related Liabilities, Current 15.6M USD -20.8%
Liabilities, Current 50.7M USD -54.8%
Operating Lease, Liability, Noncurrent 88.6M USD -11.7%
Other Liabilities, Noncurrent 7.3M USD
Liabilities 279M USD -20.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -19K USD +97.8%
Retained Earnings (Accumulated Deficit) -1.5B USD -19.6%
Stockholders' Equity Attributable to Parent 340M USD -4.33%
Liabilities and Equity 619M USD -12.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -65.6M USD +17.2%
Net Cash Provided by (Used in) Financing Activities 186M USD +78882%
Net Cash Provided by (Used in) Investing Activities -77.2M USD -223%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 222M shares +12.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.5M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 139M USD -24.7%
Deferred Tax Assets, Valuation Allowance 403M USD +46.8%
Deferred Tax Assets, Gross 425M USD +42.2%
Operating Lease, Liability 98.6M USD -12.9%
Depreciation 23.4M USD +37.8%
Payments to Acquire Property, Plant, and Equipment 15.8M USD +628%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -244M USD +31.5%
Lessee, Operating Lease, Liability, to be Paid 182M USD -23%
Property, Plant and Equipment, Gross 135M USD +28.3%
Operating Lease, Liability, Current 10M USD -22.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.5M USD -20.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 21.8M USD -22.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 83M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.9M USD -21.2%
Deferred Tax Assets, Operating Loss Carryforwards 192M USD +24.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.2M USD -33.2%
Additional Paid in Capital 1.84B USD +14.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 22.5M USD -9.02%
Share-based Payment Arrangement, Expense 37.4M USD -4.75%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%